Javascript must be enabled to continue!
Abstract TMP114: Modulation Of P75ntr Improves Neuroprotection Following Ischemic Stroke
View through CrossRef
Background:
Stroke is a serious cause of mortality in the United States. Tissue plasminogen activator (tPA) is the only effective drug. However, it increases the risk of cerebral hemorrhage due to its narrow therapeutic window. Previous studies have shown the role of neurotrophins in several brain diseases. P75
NTR
which is the receptor of tumor necrosis family is highly expressed in stroke and associated with neuronal apoptosis. Downregulation of p75
NTR
attenuates brain injury. This study aims to find the role of p75
NTR
in the outcome of stroke.
Methods:
Two different sets of experiments were performed.
1.
Young adult C57BL/6 mice were subjected to ischemic stroke using intraluminal suture model. P75
NTR
modulator (LM11A-31) was administered following stroke. Brain samples were collected 24 hours after injury.
2.
Young adult C57BL/6 and p75 heterozygous mice were subjected to stroke using Rose Bengal photothrombotic method. Mice were tested for neurobehavioral analysis and samples were collected 72h after stroke.
Results:
We found that administration of LM11A-31 significantly reduced infarction volume, edema, and hemorrhagic transformation 24h after stroke in mice. Also, LM11A-31 reduced several inflammatory markers including tumor necrosis factor- alpha (TNF-α), nuclear factor kappa-light-chain (p-NFκb/t-NFκb), and c- Jun N-terminal kinases (p-JNK/t-JNK), and significantly increased the expression of several anti-inflammatory signaling, including protein kinase B (p-Akt/t-Akt) and extracellular signal-regulated kinase ½ (p-ERK1/2/t-ERK1/2) after stroke. Furthermore, we found that p75
NTR
heterozygous mice remarkably demonstrated less infarction, edema, and hemorrhagic transformation than wild-type mice after stroke. Moreover, p75
NTR
heterozygous significantly showed better motor function.
Conclusion:
This study suggests that p75
NTR
modulation can be a potential pharmacological target for improving the outcome of ischemic stroke.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract TMP114: Modulation Of P75ntr Improves Neuroprotection Following Ischemic Stroke
Description:
Background:
Stroke is a serious cause of mortality in the United States.
Tissue plasminogen activator (tPA) is the only effective drug.
However, it increases the risk of cerebral hemorrhage due to its narrow therapeutic window.
Previous studies have shown the role of neurotrophins in several brain diseases.
P75
NTR
which is the receptor of tumor necrosis family is highly expressed in stroke and associated with neuronal apoptosis.
Downregulation of p75
NTR
attenuates brain injury.
This study aims to find the role of p75
NTR
in the outcome of stroke.
Methods:
Two different sets of experiments were performed.
1.
Young adult C57BL/6 mice were subjected to ischemic stroke using intraluminal suture model.
P75
NTR
modulator (LM11A-31) was administered following stroke.
Brain samples were collected 24 hours after injury.
2.
Young adult C57BL/6 and p75 heterozygous mice were subjected to stroke using Rose Bengal photothrombotic method.
Mice were tested for neurobehavioral analysis and samples were collected 72h after stroke.
Results:
We found that administration of LM11A-31 significantly reduced infarction volume, edema, and hemorrhagic transformation 24h after stroke in mice.
Also, LM11A-31 reduced several inflammatory markers including tumor necrosis factor- alpha (TNF-α), nuclear factor kappa-light-chain (p-NFκb/t-NFκb), and c- Jun N-terminal kinases (p-JNK/t-JNK), and significantly increased the expression of several anti-inflammatory signaling, including protein kinase B (p-Akt/t-Akt) and extracellular signal-regulated kinase ½ (p-ERK1/2/t-ERK1/2) after stroke.
Furthermore, we found that p75
NTR
heterozygous mice remarkably demonstrated less infarction, edema, and hemorrhagic transformation than wild-type mice after stroke.
Moreover, p75
NTR
heterozygous significantly showed better motor function.
Conclusion:
This study suggests that p75
NTR
modulation can be a potential pharmacological target for improving the outcome of ischemic stroke.
Related Results
Iranian stroke model-how to involve health policymakers
Iranian stroke model-how to involve health policymakers
Stroke in Iran, with more than 83 million population, is a leading cause of disability and mortality in adults. Stroke has higher incidence in Iran comparing the global situation a...
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
According to epidemiological studies, the leading cause of morbidity, disability and mortality are cerebrovascular diseases, in particular ischemic and hemorrhagic strokes. In rece...
Unveiling the Burden of Cardiovascular Disorders in Pediatric Stroke—Insights from Pakistan
Unveiling the Burden of Cardiovascular Disorders in Pediatric Stroke—Insights from Pakistan
Pediatric stroke, though relatively uncommon, poses significant clinical challenges due to its high rates of morbidity and mortality [1]. Its incidence varies with age, remaining l...
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
Hypertension, Age, Sex, and Stroke Incidence In Stroke Installation Room RSUD dr. M. Yunus BengkuluABSTRAKStroke adalah gejala-gejala defisit fungsi susunan saraf yang diakibatka...
Predictors of recurrent ischemic stroke in a sample of Egyptian stroke patients
Predictors of recurrent ischemic stroke in a sample of Egyptian stroke patients
Abstract
Background
Stroke is the third leading cause of mortality and a major cause of disability worldwide. Patients who experienced a first is...
Clinical Features, Risk Factors and Hospital Mortality of Acute Stroke Patients
Clinical Features, Risk Factors and Hospital Mortality of Acute Stroke Patients
Background: Stroke is a leading cause of mortality and disability worldwide. To prevent complications and permanent defects, early diagnosis, distinguishing the type and risk facto...
Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study
Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study
Abstract
Background
Atherogenic index of plasma (AIP) has been demonstrated as a surrogate marker for ischemic stroke, but there is limited evidence...
Gambaran Motorik Kasar Pasien Stroke Iskemik Setelah Fisioterapi di RSAU Salamun
Gambaran Motorik Kasar Pasien Stroke Iskemik Setelah Fisioterapi di RSAU Salamun
Abstract. Stroke is the second leading cause of death worldwide, accounting for 11.13% of total deaths, and is the primary cause of disability globally. The most common type of str...

